Australia Allergy And Autoimmune Disease Diagnostics Market Size & Outlook
Related Markets
Australia allergy and autoimmune disease diagnostics market highlights
- The Australia allergy and autoimmune disease diagnostics market generated a revenue of USD 222.8 million in 2024 and is expected to reach USD 618.1 million by 2033.
- The Australia market is expected to grow at a CAGR of 12.4% from 2025 to 2033.
- In terms of segment, allergy was the largest revenue generating products and services in 2024.
- Allergy is the most lucrative products and services segment registering the fastest growth during the forecast period.
Allergy and autoimmune disease diagnostics market data book summary
| Market revenue in 2024 | USD 222.8 million |
| Market revenue in 2033 | USD 618.1 million |
| Growth rate | 12.4% (CAGR from 2025 to 2033) |
| Largest segment | Allergy |
| Fastest growing segment | Allergy |
| Historical data | 2021 - 2023 |
| Base year | 2024 |
| Forecast period | 2025 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Allergy, Autoimmune Disease |
Other key industry trends
- In terms of revenue, Australia accounted for 2.0% of the global allergy and autoimmune disease diagnostics market in 2024.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
- In Asia Pacific, China allergy and autoimmune disease diagnostics market is projected to lead the regional market in terms of revenue in 2033.
- Thailand is the fastest growing regional market in Asia Pacific and is projected to reach USD 391.1 million by 2033.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Allergy And Autoimmune Disease Diagnostics Market Scope
Allergy And Autoimmune Disease Diagnostics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| DASIT Group | View profile | 101-250 | Cornaredo, Lombardia, Italy, Europe | https://dasitgroup.it |
| HOB Biotech | View profile | - | Suzhou, Jiangsu, China, Asia | http://www.hob-biotech.com |
| EUROIMMUN Medizinische Labordiagnostika | View profile | 501-1000 | Lübeck, Schleswig-Holstein, Germany, Europe | https://euroimmun.de |
| bioMerieux | View profile | 10001+ | Marcy-l'etoile, Rhone-Alpes, France, Europe | http://www.biomerieux.com |
| Lincoln Diagnostics | View profile | 11-50 | Illinois City, Illinois, United States, North America | https://www.lincolndiagnostics.com |
| Hycor Biomedical | View profile | 51-100 | Garden Grove, California, United States, North America | http://hycorbiomedical.com |
| Omega Diagnostics | View profile | 51-100 | Alva, Clackmannanshire, United Kingdom, Europe | http://www.omegadiagnostics.com |
| Minaris Medical | View profile | - | https://minarismedical.com | |
| AESKU.GROUP | View profile | 251-500 | Wendelsheim, Baden-Wurttemberg, Germany, Europe | https://www.aesku.com/ |
| R-Biopharm | View profile | 501-1000 | Darmstadt, Hessen, Germany, Europe | http://www.r-biopharm.com/ |
| Inova Diagnostics | View profile | 51-100 | San Diego, California, United States, North America | http://inovadx.com |
| Beckman Coulter | View profile | 10001+ | Brea, California, United States, North America | http://www.beckmancoulter.com |
| Quest Diagnostics Inc | View profile | 48000 | 500 Plaza Drive, Secaucus, NJ, United States, 07094 | https://www.questdiagnostics.com |
| Danaher Corp | View profile | 63000 | 2200 Pennsylvania Avenue, N.W., Suite 800W, Washington, DC, United States, 20037-1701 | https://www.danaher.com |
| Thermo Fisher Scientific Inc | View profile | 122000 | 168 Third Avenue, Waltham, MA, United States, 02451 | https://www.thermofisher.com |
| Siemens Healthineers AG ADR | View profile | 71400 | Siemensstr. 3, Forchheim, BY, Germany, 91301 | https://www.siemens-healthineers.com |
| Abbott Laboratories | View profile | 114000 | 100 Abbott Park Road, Abbott Park, IL, United States, 60064-6400 | https://www.abbottinvestor.com |
| Roche Holding AG ADR | View profile | 103605 | Grenzacherstrasse 124, Basel, Switzerland, 4070 | https://www.roche.com |
Australia allergy and autoimmune disease diagnostics market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to allergy and autoimmune disease diagnostics market will help companies and investors design strategic landscapes.
Allergy was the largest segment with a revenue share of 63.15% in 2024. Horizon Databook has segmented the Australia allergy and autoimmune disease diagnostics market based on allergy, autoimmune disease covering the revenue growth of each sub-segment from 2021 to 2033.
Reasons to subscribe to Australia allergy and autoimmune disease diagnostics market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Australia allergy and autoimmune disease diagnostics market databook
-
Our clientele includes a mix of allergy and autoimmune disease diagnostics market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Australia allergy and autoimmune disease diagnostics market , including forecasts for subscribers. This country databook contains high-level insights into Australia allergy and autoimmune disease diagnostics market from 2021 to 2033, including revenue numbers, major trends, and company profiles.
Partial client list
Australia allergy and autoimmune disease diagnostics market size, by products and services, 2021-2033 (US$M)
Australia Allergy And Autoimmune Disease Diagnostics Market Outlook Share, 2024 & 2033 (US$M)
Related industry reports
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
